Pediatric Kidney Transplantation, Ureteroneocystostomy Techniques
Launched by RADBOUD UNIVERSITY MEDICAL CENTER · May 25, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different surgical techniques used in kidney transplantation for children. Specifically, the researchers want to compare a method called non-refluxing ureteroneocystostomy (UNC) to another method called reflux UNC. They aim to see which technique leads to fewer urinary tract infections and problems with the ureters (the tubes connecting the kidneys to the bladder) in young kidney transplant recipients.
To participate in this study, children and young adults who received a kidney transplant at one of the participating centers between the ages of 0 and 19 years from 1994 to 2018 may be eligible. They should have follow-up data for at least one year after their transplant. Participants in the study can expect their past medical information to be reviewed to help understand the outcomes of these two surgical techniques. This research is important as it could help improve future kidney transplant surgeries and reduce complications for young patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • received kidney graft in the participating centres at an age \<19
- • received kidney graft between 1994-2018
- • follow-up data of at least 1 year
- Exclusion Criteria:
- • - Loss of follow up \< 1 year
About Radboud University Medical Center
Radboud University Medical Center is a leading academic medical institution located in Nijmegen, the Netherlands, dedicated to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, Radboud UMC leverages its multidisciplinary expertise to conduct high-quality research that aims to improve patient outcomes and enhance medical knowledge. The center is committed to ethical standards and regulatory compliance, fostering collaboration among researchers, healthcare professionals, and patients to translate scientific discoveries into effective clinical applications. With a focus on personalized medicine and cutting-edge technologies, Radboud University Medical Center plays a pivotal role in shaping the future of healthcare through its rigorous clinical trial initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nijmegen, Gelderland, Netherlands
Patients applied
Trial Officials
Liesbeth Lamers, MD
Principal Investigator
Radboud University Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials